K851245 is an FDA 510(k) clearance for the ADDITION OF 50% OXYGEN TO APPLINC SAVING BREATH HY. Classified as Heater, Breathing System W/wo Controller (not Humidifier Or Nebulizer within the BZE classification (a category for neonatal and pediatric respiratory circuit components), Class II - Special Controls.
Submitted by Applinc (San Diego, US). The FDA issued a Cleared decision on May 15, 1985 after a review of 49 days - a notably fast clearance cycle.
This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5270 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. Neonatal respiratory circuit components typically face extended FDA review due to heightened safety scrutiny for pediatric patient populations - the 176-day cycle reflects this additional regulatory diligence.
View all Applinc devices